Statistics

Total Visits

Views
A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results133

Select a period of time:

Number of views in the range

Views
A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results60

Views

Views
December 20258
January 20266
February 20262
March 20266
April 202617
May 202612
June 20269
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States34
Netherlands6
Colombia4
Canada2
Egypt2
Brazil2
Bolivia1
Congo1
Costa Rica1
Spain1
 

Top cities views

Views
San Jose12
Groningen6
Ashburn6
Santa Clara2
Al Ma`adi1
Alexandria1
Brazzaville1
Bucaramanga1
Heredia1
Istanbul1